Monoxyde D`azote Messer 800 Ppm (V/V) (Nitric Oxide)

Nitric Oxide, the active ingredient in Monoxyde D`azote Messer 800 Ppm (V/V), is an inhaled nitric oxide presented as a 800 ppm (v/v) medical gas for inhalation use. It is employed to treat neonatal pulmonary hypertension and acute respiratory distress syndrome in appropriate patient populations.

GNH USA supplies Monoxyde D`azote Messer 800 Ppm (V/V) as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies, clinics and research institutions worldwide.

Nitric Oxide is used as an inhaled pulmonary vasodilator to manage conditions characterized by elevated pulmonary vascular resistance.

- Neonatal pulmonary hypertension: reduces pulmonary arterial pressure, improving oxygenation in newborns. - Acute respiratory distress syndrome: lowers pulmonary vascular resistance, supporting gas exchange in critically ill patients.

Inhaled nitric oxide may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Methemoglobinemia: elevated methemoglobin levels causing reduced oxygen delivery. - Nitrogen dioxide formation: inhalation of NO₂ can irritate airways. - Rebound pulmonary hypertension: increase in pulmonary pressure after abrupt discontinuation. - Hypotension: transient systemic blood pressure reduction.

Serious or Rare Side Effects: - Severe methemoglobinemia: symptomatic levels requiring intervention. - Persistent hypotension: prolonged low blood pressure unresponsive to fluids. - Acute kidney injury: rare renal impairment linked to hemodynamic changes. - Hemorrhage: increased bleeding tendency in patients with coagulopathy.

When using inhaled nitric oxide, specific precautions are recommended to ensure patient safety and product integrity.

- Monitoring: regularly assess methemoglobin levels and NO₂ concentrations during therapy. - Discontinuation: taper the dose gradually to avoid rebound pulmonary hypertension. - Contraindications: avoid use in patients with severe anemia or known hypersensitivity to nitric oxide. - Drug interactions: be cautious when co‑administered with phosphodiesterase inhibitors or other pulmonary vasodilators. - Pregnancy and lactation: use only if the potential benefit justifies the potential risk, as safety data are limited. - Store at ambient temperature: keep cylinders in original packaging, protect from direct sunlight and extreme heat.

Nitric oxide can interact with several medications, affecting its efficacy or safety profile.

Major Interactions (Avoid): - Sildenafil or other PDE‑5 inhibitors: combined use may cause profound hypotension. - Methylene blue: antagonizes nitric oxide’s effect and may worsen methemoglobinemia. - Other inhaled pulmonary vasodilators: additive vasodilatory effect leading to severe hypotension.

Moderate Interactions (Monitor Closely): - Inhaled anesthetics (e.g., sevoflurane): may potentiate vasodilation, requiring blood pressure monitoring. - Anticoagulants: nitric oxide can enhance bleeding risk; monitor coagulation parameters. - Nitric oxide donors (e.g., nitroglycerin): may increase cumulative vasodilatory effect. - Hemoglobin‑based oxygen carriers: can alter nitric oxide scavenging, affecting dose requirements.